Oasmia

Our vision is to improve the treatment of severe diseases in order to provide benefits for both patients and society as a whole.

Read more
Investor meetings

Stockholm 25 November (live webcast)

Göteborg 27 November
Rights issue 2019

Release

Q&A regarding Rights issue in Swedish

Prospectus

Press releases

December 9, 2019 Regulatory press release
Final result of the rights issue in Oasmia
December 6, 2019 Regulatory press release
Oasmia’s rights issue has been oversubscribed
November 27, 2019
Correction: The CEO of Oasmia buys subscription rights in the ongoing rights issue

All press releases

Financial reports

Calendar

December 30, 2019 Interim Report May – October 2019
March 27, 2020 Interim Report May 2019 – January 2020
June 18, 2020 Year-end Report May 2019 – April 2020

The Share

Follow the share

We uses cookies in order to optimize your use of our website. Read more about cookies.

OK